Stay updated on Opregen in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.

Latest updates to the Opregen in Geographic Atrophy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe new screenshot shows updates to the study record metadata (last update date) and minor wording changes in the Study Overview. These changes do not alter core study details or participant eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedNew recruitment sites were added: Retina Consultants of Texas (Bellaire, TX) and Retina Vitreous Associates of Florida (St. Petersburg, FL). The total number of locations is updated to 15.SummaryDifference0.7%

- Check41 days agoChange DetectedCore content updated to include a government funding notice and new revision/version, signaling a status update; previous versioning line items were replaced with newer ones.SummaryDifference5%

- Check48 days agoChange DetectedAdded new substudy description, updated eligibility and device usage role, expanded location list (and counts), and new scheduling/version details; removed previous locations count and non-interventional wording.SummaryDifference6%

- Check62 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.3%

- Check70 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%

Stay in the know with updates to Opregen in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.